SABBY MANAGEMENT, LLC - PHIO PHARMACEUTICALS CORP ownership

Back to all holdings Add to watchlist

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 10 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2021$83,000
-29.1%
40,684
-21.4%
0.01%
-31.2%
Q2 2021$117,000
+88.7%
51,756
+125.0%
0.02%
+33.3%
Q1 2021$62,000
-86.3%
23,007
-91.0%
0.01%
-93.6%
Q1 2020$452,000–255,194–0.19%–
 Download
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 33,374$73,0000.01%
UBS Group AG 11,159$24,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 18$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HSBC HOLDINGS PLC 11,512$25,0000.00%
BlackRock Inc. 19$00.00%
Valeo Financial Advisors, LLC 250$1,0000.00%
JPMORGAN CHASE & CO 200$00.00%
Renaissance Technologies 74,182$162,0000.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders